Return to Home

Harrow, Inc.

HROW

Find Out if You Qualify for a Financial Reward by filling out the form below.

Harrow, Inc. Form












Securities Fraud News does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

On November 13, 2023, Harrow released its third quarter 2023 financial results, revising 2023 financial guidance due in part to the “compounding business underperform[ing] during the period.” The Company further released GAAP EPS and revenue figures that missed analyst estimates. Following this news, the price of the Company’s stock dropped.

Find More Cases

Ticker Symbol Company Name Join Deadline
APLT Applied Therapeutics, Inc. February 18, 2025 Join
BIOA BioAge Labs, Inc. March 10, 2025 Join
PCRX Pacira BioSciences, Inc. March 14, 2025 Join
NVO Novo Nordisk A/S March 25, 2025 Join
GO Grocery Outlet Holding Corp. March 31, 2025 Join
NEM Newmont Corporation April 01, 2025 Join
GSK GSK plc April 07, 2025 Join
NTLA Intellia Therapeutics, Inc. April 14, 2025 Join
MRK Merck & Co., Inc. April 14, 2025 Join